Multi-year analysis of the global preclinical antibacterial pipeline: trends and gaps
Valeria Gigante(World Health Organization), Alexandra Meagan Cameron(World Health Organization), César A. Arias(Universidad El Bosque), Melvin Spigelman(TB Alliance), Roman S. Kozlov(Smolensk State Medical University), F. Franceschi(Global Antibiotic Research & Development Partnership), Stephan Harbarth(University Hospital of Geneva), John Rex(AstraZeneca (Brazil)), Tamarie Rocke, Christian Lienhardt(Institut de Recherche pour le Développement), Daniela Melchiorri(Sapienza University of Rome), Richard A. Alm(AstraZeneca (United States)), Norio Ohmagari(National Center for Global Health and Medicine), Mical Paul(Rabin Medical Center), Prabhavathi Fernandes(Global Antibiotic Research & Development Partnership), Lynn L. Silver, Hatim Sati(World Health Organization), Lesley A. Ogilvie, Lloyd G. Czaplewski(University of Kent)
Cited by 25
Related Papers
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.2k
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus
|Clinical Infectious Diseases|2002|2.3k
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
|Clinical Infectious Diseases|2016|1.5k
Guidelines for Treatment of Candidiasis
|Clinical Infectious Diseases|2004|1.4k
Practice Guidelines for the Treatment of Candidiasis
|Clinical Infectious Diseases|2000|927